Cemiplimab
Stock Recap #PipelineProspector

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

October was abuzz with dealmaking. Pharma majors such as Novartis, Novo Nordisk, and Bristol Myers